packageNilotinib
nilotinib
Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).
Information
Nilotinib is a BCR-ABL tyrosine kinase inhibitor used to treat certain leukemias, notably chronic myelogenous leukemia that is BCR-ABL positive. It is authorised in the European Union and is an approved medicine, though it carries a boxed warning.
Summary written by glm-5.3-flash from Wikidata Q412327 and the WHO ATC classification and the EMA medicines list; not checked by a person.
| name: | nilotinib |
| ATC codes: | L01EA03 |
| DrugBank: | DB04868 |
| PubChem CID: | 644241 |
| ChEBI: | 52172 |
| Wikidata: | Q412327 |
| formula: | C28H22F3N7O |
| molar mass: | 529.526 g/mol (PubChem CID 644241) |
| logP: | 4.9 (Drugs.Common 25.09, not verified) |
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| String | name (from PartialSubstance) | "" | INN / common name |
| String[:] | atcCodes (from PartialSubstance) | fill("", 0) | all WHO ATC codes of the drug |
| String | drugbankId (from PartialSubstance) | "" | e.g. DB00758 |
| String | pubchemCid (from PartialSubstance) | "" | PubChem compound id |
| String | chebiId (from PartialSubstance) | "" | ChEBI id (number) |
| String | wikidataId (from PartialSubstance) | "" | e.g. Q410238 |
| String | formula (from PartialSubstance) | "" | molecular formula |
| Modelica.Units.SI.MolarMass | M (from PartialSubstance) | 0 | molar mass; 0 = unknown |
| Real | logP (from PartialSubstance) | Modelica.Constants.inf | octanol-water partition coefficient (log10); inf = unknown |